These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30790446)

  • 21. Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.
    Jiao Y; Hu F; Zhang Z; Gong K; Sun X; Li A; Liu N
    Clin Drug Investig; 2015 Dec; 35(12):777-84. PubMed ID: 26387028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India.
    Roy D; Mahapatra T; Manna K; Kar A; Rana MS; Roy A; Bose PK; Banerjee B; Paul S; Chakraborty S
    PLoS One; 2020; 15(5):e0233230. PubMed ID: 32428019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of the time of drug administration on the effectiveness of combined treatment of hypercholesterolemia with Rosuvastatin and Ezetimibe (RosEze): study protocol for a randomized controlled trial.
    Obońska K; Kasprzak M; Sikora J; Obońska E; Racki K; Goździkiewicz N; Krintus M; Kubica J
    Trials; 2017 Jul; 18(1):316. PubMed ID: 28697767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive treatment of microvascular angina in overweight women - a randomized controlled pilot trial.
    Bove KB; Nilsson M; Pedersen LR; Mikkelsen N; Suhrs HE; Astrup A; Prescott E
    PLoS One; 2020; 15(11):e0240722. PubMed ID: 33151955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
    Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
    EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.
    Kang J; Kim YC; Park JJ; Kim S; Kang SH; Cho YJ; Yoon YE; Oh IY; Yoon CH; Suh JW; Cho YS; Youn TJ; Chae IH; Choi DJ
    Cardiovasc Diabetol; 2018 Jan; 17(1):10. PubMed ID: 29325562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of high-dose atorvastatin versus rosuvastatin on lipid parameters, oxidized low-density lipoprotein, and proprotein convertase subtilisin kexin 9 in acute coronary syndrome.
    Altunkeser BB; Tuncez A; Ozturk B; Tezcan H; Ates MS; Yilmaz C; Yalcin MU; Aygul N; Demir K
    Coron Artery Dis; 2019 Jun; 30(4):285-290. PubMed ID: 30741744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study.
    Reis SE; Holubkov R; Lee JS; Sharaf B; Reichek N; Rogers WJ; Walsh EG; Fuisz AR; Kerensky R; Detre KM; Sopko G; Pepine CJ
    J Am Coll Cardiol; 1999 May; 33(6):1469-75. PubMed ID: 10334410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    Chen JW; Hsu NW; Wu TC; Lin SJ; Chang MS
    Am J Cardiol; 2002 Nov; 90(9):974-82. PubMed ID: 12398965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial.
    Peña JM; Aspberg S; MacFadyen J; Glynn RJ; Solomon DH; Ridker PM
    JAMA Intern Med; 2015 Feb; 175(2):171-7. PubMed ID: 25437881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Chogtu B; Kuriachan S; Magazine R; Shetty KR; Kamath A; George MM; Tripathy A; Kumar DM
    Indian J Pharmacol; 2016; 48(5):503-508. PubMed ID: 27721534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the Effects of Ticagrelor and Clopidogrel on Microvascular Dysfunction in Patients With Acute Coronary Syndrome Using Invasive Physiologic Indices.
    Park K; Cho YR; Park JS; Park TH; Kim MH; Kim YD
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e008105. PubMed ID: 31554423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.
    Tam LS; Li EK; Shang Q; Tomlinson B; Lee VW; Lee KK; Li M; Kuan WP; Li TK; Tseung L; Yip GW; Freedman B; Yu CM
    Scand J Rheumatol; 2011 Nov; 40(6):411-21. PubMed ID: 21867445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation.
    Oh M; Kim H; Shin EW; Sung C; Kim DH; Moon DH; Lee CW
    BMC Cardiovasc Disord; 2019 Aug; 19(1):201. PubMed ID: 31426749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients: a Multicenter, Retrospective Cohort Study.
    Chen Y; Li D; Jing J; Yan H; Liu J; Shen Z; James S; Varenhorst C
    Clin Ther; 2017 Sep; 39(9):1827-1839.e1. PubMed ID: 28807393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Thromb Res; 2017 Feb; 150():90-95. PubMed ID: 28068529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
    Puri R; Nissen SE; Libby P; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Circulation; 2013 Nov; 128(22):2395-403. PubMed ID: 24043299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of rosuvastatin as an adjuvant treatment for deep vein thrombosis.
    San Norberto EM; Gastambide MV; Taylor JH; García-Saiz I; Vaquero C
    Vasa; 2016; 45(2):133-40. PubMed ID: 27058799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
    Fellström BC; Jardine AG; Schmieder RE; Holdaas H; Bannister K; Beutler J; Chae DW; Chevaile A; Cobbe SM; Grönhagen-Riska C; De Lima JJ; Lins R; Mayer G; McMahon AW; Parving HH; Remuzzi G; Samuelsson O; Sonkodi S; Sci D; Süleymanlar G; Tsakiris D; Tesar V; Todorov V; Wiecek A; Wüthrich RP; Gottlow M; Johnsson E; Zannad F;
    N Engl J Med; 2009 Apr; 360(14):1395-407. PubMed ID: 19332456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease.
    Suda A; Takahashi J; Hao K; Kikuchi Y; Shindo T; Ikeda S; Sato K; Sugisawa J; Matsumoto Y; Miyata S; Sakata Y; Shimokawa H
    J Am Coll Cardiol; 2019 Nov; 74(19):2350-2360. PubMed ID: 31699275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.